*1 patient received Q4W and 1 patient received Q6W dosing.
CD: Crohn’s disease; HBI: Harvey-Bradshaw Index; q8w: Every 8 weeks; SC: Subcutaneous; TNF: Tumour necrosis factor.
† Clinical remission (HBI ≤4), and steroid-free remission (HBI ≤4 and no systemic use of steroids or budesonide during the last 8 weeks).
‡ Other biologics included adalimumab (50.3%), infliximab (37.4%) and vedolizumab (12.3%).
§ Includes mobility, self-care, usual activities, pain/discomfort and anxiety/depression.